Quanterix Corporation
Quanterix Corporation (QTRX) is a small-cap diagnostics company that makes ultra-sensitive immunoassay instruments and assays under its Simoa (single molecule array) platform. Investors should know Quanterix sells analytical instruments and consumable assays used by research labs and clinical partners to detect low-abundance biomarkers across neurology, oncology and other fields. The business model mixes instrument sales with recurring reagent and service revenues, but growth depends on broader clinical adoption of its assays, partnership deals, and continued product development. With a market cap near $281.6m, the company faces typical biotech and device risks — regulatory hurdles, competition from incumbent laboratory platforms, and periodic capital needs. Potential upside comes from expanded clinical use, higher reagent attach rates and new assays, while performance can be volatile and past performance is not a guide to future returns. This is general educational information, not personalised investment advice.
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Quanterix Corporation's stock as its value might not increase significantly soon.
Financial Health
Quanterix Corporation is generating strong revenue and cash flow, indicating good financial performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring QTRX
Diagnostic Takeover Targets
This carefully selected group of stocks features innovative diagnostic companies that could become acquisition targets following recent takeover interest in the sector. Professional analysts have identified these companies for their unique technologies and established market positions in a consolidating healthcare landscape.
Published: July 15, 2025
Explore BasketLiquid-Biopsy Diagnostics
These innovative companies are developing revolutionary blood tests that can detect cancer earlier and more accurately than ever before. Carefully selected by healthcare investment experts, this collection represents the forefront of non-invasive diagnostics poised to transform the multi-billion dollar oncology market.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Recurring revenue potential
Instrument sales can lead to steady consumable and reagent revenue, which may support long-term growth — though recurring sales can vary with adoption rates.
Clinical adoption focus
Wider use of Simoa assays in neurology and oncology could expand addressable markets, but adoption depends on regulatory approval and clinician uptake.
Technology edge
Ultra‑sensitive single-molecule detection differentiates the platform; however, competition and execution risks mean outcomes can be uncertain.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
